You are here: Industry Insights > COVID-19 Vaccine

News List

Biological E signs tech transfer pacts with Baylor College of Medicine and J&J for COVID-19 vaccine expresspharma
August 14, 2020
The agreements are for Baylor's recombinant protein vaccine candidate and J&J's Ad26.COV2.S vaccine, currently in Phase 1/2 clinical trials.
Russia approves world’s first Covid-19 vaccine pharmaceutical-technology
August 13, 2020
Russia has awarded regulatory approval to a Covid-19 vaccine, becoming the first country in the world to register a coronavirus vaccine for use.
Takeda to license Novavax’ Covid-19 vaccine candidate NVX‑CoV2373 pharmaceutical-business-review
August 12, 2020
Novavax has agreed to grant the Japanese licensing rights to NVX‑CoV2373, a vaccine candidate modified from the genetic sequence of the Covid-19 causing SARS‑CoV‑2 virus, to Takeda Pharmaceutical.
mRNA vaccines the most promising among emerging COVID-19 vaccines: Poll pharmaceutical-technology
August 12, 2020
Vaccination is being considered as the only way the coronavirus pandemic can be controlled, although a highly effective vaccine is not expected to be available in less than a year.
US signs $1.5 bn deal with Moderna for 100 mn doses of COVID-19 vaccine expresspharma
August 12, 2020
Moderna’s deal with the US only pays out in full if the company hits certain unspecific timing benchmarks for vaccine delivery.
Success of indigenous COVID-19 vaccines will make access easy and affordable in India: GlobalData expresspharma
August 12, 2020
India is making rapid progress in the development of indigenous COVID-19 vaccines. With an increase in the number of COVID-19 positive cases, their success will make access easy and affordable for Indians, says GlobalData, data and analytics company.
Novavax partners with Takeda to develop Covid-19 vaccine in Japan pharmaceutical-technology
August 11, 2020
US-based biotechnology firm Novavax has partnered with Takeda Pharmaceutical to develop, manufacture and commercialise its Covid-19 vaccine candidate, NVX‑CoV2373, in Japan.
CanSino to commence Phase III COVID-19 vaccine trial in Saudi Arabia expresspharma
August 11, 2020
The vaccine uses adenovirus type-5 (Ad5) to carry genetic material from the coronavirus into the body.
SII, Gavi and BMGF collaborate for COVID-19 vaccines, SII to price per vaccine dose at Rs 225 expresspharma
August 10, 2020
Serum Institute of India to produce up to 100 million COVID-19 vaccine doses which will be made available to the 92 countries included in Gavi’s COVAX Advance Market Commitment.
Russia to register COVID-19 vaccine on August 12 expresspharma
August 10, 2020
The vaccine is jointly developed by Gamaleya Research Institute and the Russian Defence Ministry.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 116 117 Next page